Topiramate Extended Release: A Review in Epilepsy-Reference-Cited by-同舟云学术

Topiramate Extended Release: A Review in Epilepsy

Published:2016-05-25 Issue:6 Volume:30 Page:559-566
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Hoy Sheridan M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40263-016-0344-5.pdf

Reference17 articles.

1. Al-Aqeel S, Al-Sabhan J. Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. Cochrane Database Syst Rev. 2011;(1):CD008312.

2. Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat. 2007;3(1):117–31.

3. Bialer M. Extended-release formulations for the treatment of epilepsy. CNS Drugs. 2007;21(9):765–74.

4. Upsher-Smith Laboratories Inc. QUDEXY XR (topiramate) extended-release capsules, for oral use: US prescribing information. 2015. http://www.fda.gov/ . Accessed 3 May 2016.

5. Shank RP, Gardocki JF, Streeter AJ, et al. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia. 2000;41(Suppl 1):S3–9.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant predictors for topiramate pharmacokinetics: a systematic review of population pharmacokinetic studies;Journal of Pharmacy Practice and Research;2022-03-22

2. Drug treatment of epilepsy: From serendipitous discovery to evolutionary mechanisms;Current Medicinal Chemistry;2021-09-10

3. Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy;Journal of Clinical Neurology;2020

4. Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension;Fluids and Barriers of the CNS;2019-11-26

5. The application of text mining algorithms in summarizing trends in anti-epileptic drug research;2018-02-22